Article
Dose-dependent efficacy and safety toxicology of hydroxypyridinonate actinide decorporation agents in rodents: towards a safe and effective human dosing regimen.
Radiation research - 1 Feb 2013
Bunin Deborah I, Chang Polly Y, Doppalapudi Rupa S, Riccio Edward S, An Dahlia, Jarvis Erin E, Kullgren Birgitta, Abergel Rebecca J
Abstract excerpt
Two hydroxypyridinone-containing actinide decorporation agents, 3,4,3-LI(1,2-HOPO) and 5-LIO(Me-3,2-HOPO), are being developed for the treatment of internal actinide contamination by chelation therapy. Dose-response efficacy profiles in mice were established for the removal of intravenously injected (238)Pu and (241)Am after parenteral and oral treatment with these chelators. In both cases, presumed efficacious...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
